EKF Diagnostics Holdings Plc (EKF) - Total Assets
Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) holds total assets worth GBX81.14 Million GBX (≈ $9.87K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check EKF cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
EKF Diagnostics Holdings Plc - Total Assets Trend (2001–2025)
This chart illustrates how EKF Diagnostics Holdings Plc's total assets have evolved over time, based on quarterly financial data. Explore EKF long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
EKF Diagnostics Holdings Plc - Asset Composition Analysis
Current Asset Composition (December 2025)
EKF Diagnostics Holdings Plc's total assets of GBX81.14 Million consist of 38.1% current assets and 62.0% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 19.5% |
| Accounts Receivable | GBX6.74 Million | 8.3% |
| Inventory | GBX8.30 Million | 10.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX3.75 Million | 4.6% |
| Goodwill | GBX24.14 Million | 29.8% |
Asset Composition Trend (2001–2025)
This chart illustrates how EKF Diagnostics Holdings Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see EKF Diagnostics Holdings Plc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EKF Diagnostics Holdings Plc's current assets represent 38.1% of total assets in 2025, an increase from 3.8% in 2001.
- Cash Position: Cash and equivalents constituted 19.5% of total assets in 2025, up from 0.3% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 33.0% of total assets, a decrease from 95.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 29.8% of total assets.
EKF Diagnostics Holdings Plc Competitors by Total Assets
Key competitors of EKF Diagnostics Holdings Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
EKF Diagnostics Holdings Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.16 | 4.44 | 2.26 |
| Quick Ratio | 3.04 | 3.29 | 1.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX23.45 Million | GBX22.11 Million | GBX24.54 Million |
EKF Diagnostics Holdings Plc - Advanced Valuation Insights
This section examines the relationship between EKF Diagnostics Holdings Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.55 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | GBX81.14 Million |
| Market Capitalization | $1.36 Million USD |
Valuation Analysis
Below Book Valuation: The market values EKF Diagnostics Holdings Plc's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: EKF Diagnostics Holdings Plc's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for EKF Diagnostics Holdings Plc (2001–2025)
The table below shows the annual total assets of EKF Diagnostics Holdings Plc from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | GBX81.14 Million ≈ $9.87K |
-0.74% |
| 2024-12-31 | GBX81.75 Million ≈ $9.95K |
+1.11% |
| 2023-12-31 | GBX80.85 Million ≈ $9.84K |
-9.45% |
| 2022-12-31 | GBX89.29 Million ≈ $10.86K |
-22.44% |
| 2021-12-31 | GBX115.12 Million ≈ $14.01K |
+13.68% |
| 2020-12-31 | GBX101.27 Million ≈ $12.32K |
+16.23% |
| 2019-12-31 | GBX87.13 Million ≈ $10.60K |
+7.06% |
| 2018-12-31 | GBX81.38 Million ≈ $9.90K |
+5.47% |
| 2017-12-31 | GBX77.16 Million ≈ $9.39K |
-6.40% |
| 2016-12-31 | GBX82.43 Million ≈ $10.03K |
+14.67% |
| 2015-12-31 | GBX71.89 Million ≈ $8.75K |
-47.05% |
| 2014-12-31 | GBX135.78 Million ≈ $16.52K |
+123.60% |
| 2013-12-31 | GBX60.72 Million ≈ $7.39K |
+8.98% |
| 2012-12-31 | GBX55.72 Million ≈ $6.78K |
-5.14% |
| 2011-12-31 | GBX58.73 Million ≈ $7.15K |
+63.24% |
| 2010-12-31 | GBX35.98 Million ≈ $4.38K |
+462.44% |
| 2009-12-31 | GBX6.40 Million ≈ $778.33 |
+11.48% |
| 2008-12-31 | GBX5.74 Million ≈ $698.15 |
+3.11% |
| 2007-12-31 | GBX5.57 Million ≈ $677.10 |
+7.83% |
| 2006-12-31 | GBX5.16 Million ≈ $627.94 |
+6.57% |
| 2005-12-31 | GBX4.84 Million ≈ $589.25 |
-27.25% |
| 2004-12-31 | GBX6.66 Million ≈ $809.96 |
+5.23% |
| 2003-12-31 | GBX6.33 Million ≈ $769.69 |
+1033.69% |
| 2003-06-30 | GBX558.00K ≈ $67.89 |
-91.32% |
| 2002-12-31 | GBX6.43 Million ≈ $782.59 |
+18.06% |
| 2001-12-31 | GBX5.45 Million ≈ $662.86 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more